Drugs / H P Acthar
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02764697 | Jun → Dec 2016 | anterior uveitis, intermediate uveitis, macular retinal edema, posterior uveitis +1 | Tampa Bay Uveitis Center, LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | H P Acthar | “Subjects will be treated with H P Acthar subcutaneous gel, 40 U/ml” NCT02764697 ↗ |
| Route | Subcutaneous | “Subcutaneous injection twice weekly” NCT02764697 ↗ |